Merck & Co. (MRK)
(Delayed Data from NYSE)
$85.98 USD
-0.30 (-0.35%)
Updated Oct 31, 2025 04:00 PM ET
After-Market: $86.10 +0.12 (0.14%) 7:58 PM ET
4-Sell of 5 4
B Value D Growth B Momentum B VGM
Fundamental Charts
About Market Cap
As of the previous market close, Merck & Co., Inc. has a market cap of $215.51B, which represents its share price of $86.28 multiplied by its outstanding shares number of 2.50B. As a large-cap company, MRK's shareholders are generally exposed to less risk than shareholders of small and mid-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
MRK 85.98 -0.30(-0.35%)
Will MRK be a Portfolio Killer in November?
Zacks Investment Research is releasing its prediction for MRK based on the 1-3 month trading system that more than doubles the S&P 500.

Zacks News for MRK
MRK Beats Q3 Earnings Estimates, Narrows 2025 Sales View, Stock Down
Merck (MRK) Reports Q3 Earnings: What Key Metrics Have to Say
MRK: What are Zacks experts saying now?
Zacks Private Portfolio Services
Merck (MRK) Q3 Earnings and Revenues Beat Estimates
Should You Buy, Hold, or Sell GILD Stock Ahead of Q3 Earnings?
Buy, Sell or Hold MRK Stock Ahead of Q3 Earnings? Things to Know
Other News for MRK
Earnings Scorecard: 24 out of 25 healthcare firms deliver EPS wins this week
MRK forms Non-ADX 1,2,3,4 Bullish on October 31
5 Relatively Secure And Cheap Dividend Stocks, Yields Up To 8% (Nov. 2025)
Merck & Co. Hold Rating: Navigating Stabilized Revenue and Keytruda’s Exclusivity Challenges
Merck & Co. Earnings Call Highlights Strong Growth